Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Cirata Share Price
  4. Cirata Share Regulatory News
  5. $700K Multiyear Data Integration Contract Renewal

Pin to quick picksCirata Regulatory News (CRTA)

Cirata Information

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
16.95    -0.55 (-3.14%)
Bid:
16.80
Ask:
16.95
Spread: 0.15 (0.893%)
Market Cap: £21.42m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

$700K Multiyear Data Integration Contract Renewal

30 Jun 2025 07:00

RNS Number : 8595O
Cirata PLC
30 June 2025
 

30 June 2025

Cirata plc

("Cirata" or the "Company")

$700K Multiyear Data Integration Contract Renewal with Leading Canadian Bank

Cirata plc (LSE: CRTA) is pleased to announce a $700,000, two-year Data Integration (DI) software contract win with a top five Canadian bank. This renewal represents confidence in Cirata and its implementation of Live Data Migrator ('LDM') across multiple use cases, including data migration, synchronisation, and disaster recovery. This contract will be transacted through Google Marketplace.

 

This announcement contains inside information under the UK Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Cirata is Stephen Kelly, Chief Executive Officer. 

For further information, please contact: 

 

Cirata

Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ricardo Moura, Chief Financial Officer

Dan Hayes, Investor Relations

 

 

FTI Consulting

+44 (0) 20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

 

 

 

Stifel (Nomad and Joint Broker)

+44 (0) 20 7710 7600

Fred Walsh / Brough Ransom / Ben Good

 

 

 

Panmure Liberum (Joint Broker)

+44 (0) 20 3100 2000

Max Jones / John More

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEALKNALLSEFA
123
Date   Source Headline
30th Sep 20247:00 amRNSHCSC Contract Renewal
25th Sep 20247:00 amRNSAppointment of Interim CFO
19th Sep 202410:30 amRNSHolding(s) in Company
19th Sep 202410:30 amRNSHolding(s) in Company
4th Sep 20247:00 amRNSInterim results
31st Jul 20245:44 pmRNSHolding(s) in Company
31st Jul 20242:35 pmRNSDirector/PDMR Shareholding
26th Jul 20241:51 pmRNSHolding(s) in Company
19th Jul 20245:54 pmRNSDelay of Admission
17th Jul 20247:00 amRNSResult of Fundraising
16th Jul 20244:47 pmRNSPrimaryBid Offer
16th Jul 20244:46 pmRNSLaunch of Fundraise
16th Jul 20244:45 pmRNSQ2 Trading Update and Outlook
28th Jun 20248:00 amRNSBlock Listing Return
25th Jun 20247:08 amRNSGM Launches Phase 2
19th Jun 20247:00 amRNSTotal Voting Rights
21st May 20247:00 amRNSOPPO Contract Renewal
14th May 20243:28 pmRNSResult of Annual General Meeting
29th Apr 20245:01 pmRNSFurther re: Annual Report & Notice of AGM
24th Apr 20247:00 amRNSDirectorate Change
17th Apr 20243:05 pmRNSAnnual Report & Notice of AGM
9th Apr 20247:00 amRNSQ1 FY24 Trading Update
4th Apr 20247:00 amRNSFinal Results
6th Mar 20245:19 pmRNSHolding(s) in Company
4th Mar 20242:53 pmRNSHolding(s) in Company
21st Feb 20241:27 pmRNSHolding(s) in Company
15th Feb 20244:27 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSChair appointment
9th Jan 20247:00 amRNSTrading Update
4th Jan 20243:10 pmRNSTotal Voting Rights
4th Jan 20242:41 pmRNSHolding(s) in Company
3rd Jan 20245:40 pmRNSHolding(s) in Company
2nd Jan 20249:32 amRNSNotice of Q4 FY23 Trading Update
14th Dec 20236:12 pmRNSBlock Listing Application
12th Dec 20235:32 pmRNSGrant of Share Options to PDMRs
12th Dec 20238:29 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTotal Voting Rights
5th Dec 202310:25 amRNSHolding(s) in Company
24th Nov 20235:40 pmRNSDirector/PDMR Shareholding
23rd Nov 202310:08 amRNSHolding(s) in Company
21st Nov 20235:41 pmRNSHolding(s) in Company
21st Nov 20231:28 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
17th Nov 20235:54 pmRNSDirector/PDMR Shareholding
8th Nov 20231:18 pmRNSHolding(s) in Company
7th Nov 20232:39 pmRNSTotal Voting Rights
2nd Nov 20237:00 amRNSChange of Auditor
27th Oct 20235:12 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSTrading Update and Outlook
123

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
MIRL
MIRL.L
LSE
0.00%
FUSP
Usqtyincgbpach
LSE
-0.29%
GFRD
Galliford Try
LSE
-0.57%
EAT
European Assets Trust
LSE
0.00%
PNN
Pennon
LSE
0.19%
Trending
SBTX
Skinbiotherap.
LSE
0.00%
IMM
Immupharma
LSE
-2.26%
ALRT
Defence Holdings
LSE
19.05%
PREM
Premier African Minerals
LSE
9.52%